Effects of AMR101 on Lipid and Inflammatory Parameters in Patients with Diabetes Mellitus-2 and Residual Elevated Triglycerides (200-500 mg/dL) on Statin Therapy at LDL-C Goal: The ANCHOR Study http://www.abstractsonline.com/Plan/ViewAbstract.aspx?sKey=0f3edb40-387b-45d4-b9ad-a9d1386729fd&cKey=5aa3639c-c185-428a-bbd9-026d16580286&mKey=%7b0F70410F-8DF3-49F5-A63D-3165359F5371%7d I am only posting this because I secretly know AMRN is Dew's largest holding LOL